Novartis Tests Blood In APAC; Goes For Deeper Penetration With NAT Tests
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Novartis Diagnostics dominated a large number of Western markets with its nucleic acid testing assays for donated blood, and now the Novartis unit is aiming to mirror that success in the Asia-Pacific region by aligning with private institutions, collaborating with progressive states in countries like India and working closely with non-governmental organizations